Insights

Gathering insights about InnoVent…

Similar companies to InnoVent

InnoVent Tech Stack

InnoVent uses 8 technology products and services including Open Graph, RSS, Twemoji, and more. Explore InnoVent's tech stack below.

Open Graph
Content Management System
RSS
Content Management System
Twemoji
Font Scripts
JSON-LD
Javascript Frameworks
Ubuntu
Operating Systems
Google Analytics
Web Analytics
RankMath SEO
Web Platform Extensions
Apache
Web Servers

Media & News

Innovent Biologics Strikes Partnership Deal With Eli Lilly
Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.
Feb 09, 2026 | www.wsj.com
China's Innovent clinches new Lilly deal for immunology, cancer drug development
China's Innovent Biologics has struck a new deal with Eli Lilly to develop immunology and oncology drugs, under which the U.S. drugmaker will pay $350 million upfront and as much as $8.5 billion more if milestones are met.
Feb 08, 2026 | www.reuters.com
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Company ("Lilly") to advance novel medicines in oncology and immunology. This agreement marks the seventh collaboration between the two companies, deepening a longstanding and productive partnership to deliver new medicines for patients worldwide.
Feb 08, 2026 | www.prnewswire.com
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announced that its anti-GPRC5D/BCMA/CD3 tri-specific antibody IBI3003 has received Fast Track Designation (FTD) from the U.S. Food and Drug Administration (FDA). This designation applies to the treatment of relapsed or refractory multiple myeloma, (R/R MM) in patients who have received four or more lines of previous anti-myeloma therapies, that include at least a proteasome inhibitor (PI), an immunomodulatory drug (IMiD), and an anti-CD38 monoclonal antibody.
Jan 26, 2026 | www.prnewswire.com
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported positive topline results from its randomized, head-to-head Phase 1b JADE clinical study comparing IBI324 (Ollin R&D code:OLN324), a next-generation VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in over 160 patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). OLN324's up to 60-fold higher anti-Ang2 potency together with a smaller protein format and a higher molar dose gives OLN324 a differentiated, first-line standard of care profile.
Jan 08, 2026 | www.prnewswire.com
Novo Nordisk Halves Wegovy Prices In China Ahead Of Generic Threat
Novo Nordisk has lowered prices for its obesity drug Wegovy by 50% in China, ahead of generic competition.
Dec 29, 2025 | www.benzinga.com
China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR) colon cancer. The TABOSUN® and TYVYT® combination therapy significantly improved pathological complete response (pCR) rates and enabled most patients to avoid the burden of postoperative adjuvant chemotherapy.
Dec 25, 2025 | www.prnewswire.com

InnoVent's Email Address Formats

InnoVent uses at least 1 format(s):

InnoVent Email Formats	Example	Percentage
FLast@innovent.fr	JDoe@innovent.fr	50%
FLast@innovent.fr	JDoe@innovent.fr	50%

Frequently Asked Questions

Where is InnoVent's headquarters located?

InnoVent's main headquarters is located at 5 Rue Horus Villeneuve-d'ascq, Hauts-de-france 59650 France. The company has employees across 5 continents, including EuropeAfricaAsia.

What is InnoVent's stock symbol?

InnoVent is a publicly traded company; the company's stock symbol is IVBXF.

What is InnoVent's official website and social media links?

InnoVent's official website is innovent.fr and has social profiles on LinkedIn.

What is InnoVent's SIC code NAICS code?

InnoVent's SIC code is 4899 - Communications Services, Not Elsewhere Classified NAICS code is 2211 - Electric Power Generation, Transmission and Distribution.

How many employees does InnoVent have currently?

As of February 2026, InnoVent has approximately 114 employees across 5 continents, including EuropeAfricaAsia. Key team members include Ceo, Founder: J. Q.Chief Financial Officer: G. C.Deputy Chief Financial Officer: A. M.. Explore InnoVent's employee directory with LeadIQ.

What industry does InnoVent belong to?

InnoVent operates in the Renewable Energy Power Generation industry.

What technology does InnoVent use?

InnoVent's tech stack includes Open GraphRSSTwemojiJSON-LDUbuntuGoogle AnalyticsRankMath SEOApache.

What is InnoVent's email format?

InnoVent's email format typically follows the pattern of FLast@innovent.fr. Find more InnoVent email formats with LeadIQ.

When was InnoVent founded?

InnoVent was founded in 2001.

InnoVent

Q: What is InnoVent's official website and social media links?

InnoVent's official website is innovent.fr. InnoVent has social profiles on LinkedIn.

Q: How many employees does InnoVent have currently?

InnoVent has approximately 114 employees.

Q: What technology does InnoVent use?

InnoVent's tech stack includes DigitalOcean Web Hosting, Handlebars, WordPress, Font Awesome, Priority Hints.

Renewable Energy Power GenerationHauts-de-france, France51-200 Employees

InnoVent has been using its internal resources and specialist partners to respond to the full range of issues linked to the development, construction and operation of wind and solar farms. With such knowledge, InnoVent is an experienced company that is well recognized in its field. 

InnoVent also has a long-term vision : InnoVent has chosen to export its 
know-how in solar farms and wind turbines to ten countries in Africa and has set up InnoSun, Innowind and InnoVent.

InnoVent is investing its resources into research and development in new materials and in biogas, energy storage and wind turbines.

Today, InnoVent commits to expand its activities in France and in Africa, operating and taking decisions independently. Together with the current projects we are busy with new ones that are to be developed in the next few months, while others are about to be commissioned.